Inhibitory Effects of Urolithins, Bioactive Gut Metabolites from Natural Polyphenols, against Glioblastoma Progression
Nutrients · 21.11.2023 · 15 (23) · 4854
DOI: 10.3390/nu15234854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 21.11.2023. Verfasst von Ching-Kai Shen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Science, China Medical University, Taichung 404328, Taiwan. Hauptthemen laut MEDLINE: B7-H1 Antigen, Glioblastoma. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, China Medical University, Taiwan, China Medical University Hospital, Taiwan.
Abstract (Originalsprache)
We previously reported that proinflammatory cytokines, particularly tumor necrosis factor (TNF)-α, promoted tumor migration, invasion, and proliferation, thus worsening the prognosis of glioblastoma (GBM). Urolithins, the potent metabolites produced by the gut from pomegranate polyphenols, have anticancer properties. To develop an effective therapy for GBM, this study aimed to study the effects of urolithins against GBM. Urolithin A and B significantly reduced GBM migration, reduced epithelial–mesenchymal transition, and inhibited tumor growth. Moreover, urolithin A and B inhibited TNF-α-induced vascular cell adhesion molecule (VCAM)-1 and programmed death ligand 1 (PD-L1) expression, thereby reducing human monocyte (HM) binding to GBM cells. Aryl hydrocarbon receptor (AhR) level had higher expression in patients with glioma than in healthy individuals. Urolithins are considered pharmacological antagonists of AhR. We demonstrated that the inhibition of AhR reduced TNF-α-stimulated VCAM-1 and PD-L1 expression. Furthermore, human macrophage condition medium enhanced expression of PD-L1 in human GBM cells. Administration of the AhR antagonist attenuated the enhancement of PD-L1, indicating the AhR modulation in GBM progression. The modulatory effects of urolithins in GBM involve inhibiting the Akt and epidermal growth factor receptor pathways. The present study suggests that urolithins can inhibit GBM progression and provide valuable information for anti-GBM strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Biomedical Science, China Medical University, Taichung 404328, Taiwan.
- School of Medicine, Tzu Chi University, Taichung 404, Taiwan.
- Department of Neurosurgery, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 404, Taiwan.
- Department of Pharmacology, School of Medicine, China Medical University, Taichung 404328, Taiwan.
- Department of Physiology, School of Medicine, China Medical University, Taichung 40402, Taiwan.
- Laboratory for Neural Repair, China Medical University Hospital, Taichung 404327, Taiwan.
ORCID-Profile: Vichuda Charoensaensuk, Dah-Yuu Lu, Wei-Lan Yeh
Förderung
- National Science and Technology Council, Taiwan
- China Medical University, Taiwan
- China Medical University Hospital, Taiwan
- Taichung Tzu Chi Hospital
Zitieren
APA
Shen, C. K., Huang, B. R., Charoensaensuk, V., Yang, L. Y., Tsai, C. F., Liu, Y. S., Lai, S. W., Lu, D. Y., Yeh, W. L., & Lin, C. (2023). Inhibitory Effects of Urolithins, Bioactive Gut Metabolites from Natural Polyphenols, against Glioblastoma Progression. Nutrients, 15(23), 4854. https://doi.org/10.3390/nu15234854
Vancouver
Shen CK, Huang BR, Charoensaensuk V, Yang LY, Tsai CF, Liu YS, et al. Inhibitory Effects of Urolithins, Bioactive Gut Metabolites from Natural Polyphenols, against Glioblastoma Progression. Nutrients. 2023;15(23):4854. doi:10.3390/nu15234854
BibTeX
@article{Shen2023,
author = {Shen, Ching-Kai and Huang, Bor-Ren and Charoensaensuk, Vichuda and Yang, Liang-Yo and Tsai, Cheng-Fang and Liu, Yu-Shu and Lai, Sheng-Wei and Lu, Dah-Yuu and Yeh, Wei-Lan and Lin, Chingju},
title = {Inhibitory Effects of Urolithins, Bioactive Gut Metabolites from Natural Polyphenols, against Glioblastoma Progression},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {23},
pages = {4854},
doi = {10.3390/nu15234854}
}
EUVIMED